19 May 2022
Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy
21 Apr 2022
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
14 Mar 2022
Assessing dysferlinopathy patients over three years with a new motor scale
10 Jan 2022
Exploring new therapeutic approaches in FSHD by small molecules modulation of endogenous microRNA
06 Dec 2021
An alternative to corticosteroid for the treatment of Duchenne Muscular Dystrophy
01 Nov 2021
Demonbreun et al identify a novel antibody mediated therapeutic strategy for Duchenne muscular dystrophy based on previous genetic modifier studies.
01 Oct 2021
Severe COVID-19 is associated with post-infectious inflammatory myopathy
02 Sep 2021
Establishing the validity of motor outcome measures in young boys with Duchenne Muscular Dystrophy is critical for the success of future trials
02 Aug 2021
Exploring myonuclear heterogeneity and compartmentalization of muscle fiber...
01 Jul 2021
Distinctive features of LRP12-oculopharyngeal muscular dystrophy
04 Jun 2021
Evidence of functionality of induced dystrophin following therapeutic intervention in Duchenne patient
Page 1 of 1, showing 11 records out of 11 total.